RVL Pharmaceuticals PLC (RVLPQ)
0.00
USD |
OTCM |
May 22, 16:00
RVL Pharmaceuticals Max Drawdown (5Y): 100.00% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 100.00% |
| March 31, 2024 | 100.00% |
| February 29, 2024 | 100.00% |
| January 31, 2024 | 100.00% |
| December 31, 2023 | 99.98% |
| November 30, 2023 | 99.96% |
| October 31, 2023 | 99.96% |
| September 30, 2023 | 99.12% |
| August 31, 2023 | 98.81% |
| July 31, 2023 | 95.75% |
| June 30, 2023 | 93.91% |
| May 31, 2023 | 91.63% |
| April 30, 2023 | 90.87% |
| March 31, 2023 | 89.30% |
| February 28, 2023 | 89.30% |
| January 31, 2023 | 89.30% |
| December 31, 2022 | 89.30% |
| November 30, 2022 | 89.30% |
| October 31, 2022 | 89.30% |
| September 30, 2022 | 89.30% |
| August 31, 2022 | 89.30% |
| July 31, 2022 | 89.30% |
| June 30, 2022 | 89.30% |
| May 31, 2022 | 89.30% |
| April 30, 2022 | 89.30% |
| Date | Value |
|---|---|
| March 31, 2022 | 89.30% |
| February 28, 2022 | 89.30% |
| January 31, 2022 | 89.30% |
| December 31, 2021 | 89.30% |
| November 30, 2021 | 85.54% |
| October 31, 2021 | 80.65% |
| September 30, 2021 | 74.57% |
| August 31, 2021 | 74.57% |
| July 31, 2021 | 74.57% |
| June 30, 2021 | 74.57% |
| May 31, 2021 | 74.57% |
| April 30, 2021 | 74.57% |
| March 31, 2021 | 74.57% |
| February 28, 2021 | 74.57% |
| January 31, 2021 | 74.57% |
| December 31, 2020 | 74.57% |
| November 30, 2020 | 74.57% |
| October 31, 2020 | 74.57% |
| September 30, 2020 | 74.57% |
| August 31, 2020 | 74.57% |
| July 31, 2020 | 74.57% |
| June 30, 2020 | 74.57% |
| May 31, 2020 | 74.57% |
| April 30, 2020 | 74.57% |
| March 31, 2020 | 74.57% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
74.13%
Minimum
May 2019
100.00%
Maximum
Jan 2024
83.78%
Average
83.10%
Median
Max Drawdown (5Y) Benchmarks
| NovaBay Pharmaceuticals Inc | 99.91% |
| Palatin Technologies Inc | 96.46% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |
| Oragenics Inc | 98.92% |